Factors underlying superior hypertension control in the US
This article has no abstract so we have provided the first paragraph of the full text.
Guidelines for the treatment of hypertension are more aggressive in the US than elsewhere. To determine whether differences in guidelines translate into differences in clinical variables, Wang et al. analyzed data for the year 2004 from CardioMonitor—an ongoing, nationally representative survey of physician visits made by patients with cardiovascular diseases. The data set included 21,053 adults with hypertension who had visited 1,284 primary care physicians and 291 cardiologists in France, Germany, Italy, Spain, the UK or the US.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
